mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.02 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.03 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |